We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…
HLTH 2022: Calibrate Launches Enterprise Product to Bring GLP1 Weight Loss Drugs to Payers/Employers
Startups Chasing the $100 Billion Market for Weight-Loss Drugs
CEO of Ozempic prescription startup Calibrate steps down as investors eye 'rapid downsizing' of consumer business
Rebecca Torrence on LinkedIn: Inside the struggles at Calibrate, a new kind of weight-loss startup…
By Pioneering Metabolic Health, We're Changing the Way the World Treats Weight
With the GLP-1 market expected to surpass $100B in revenue, all eyes are on telehealth
Claudia Jayne (@claudiajayne) / X
Marina Tarasova, Paloma Health, on modernizing thyroid care by The Pulse by Wharton Digital Health
How we're building the team and the tools to fight biology with biology, by Isabelle Kenyon
August 2021 – The Health Care Blog
Have You Heard The News?
How we're building the team and the tools to fight biology with biology, by Isabelle Kenyon
Isabelle Kenyon, CEO & Founder of Calibrate, on setting a new standard of care for managing metabolic health, by Cate Stanton, The Pulse by Wharton Digital Health
